Atopic Dermatitis – J4E-MC-IMMB (ISA FR01)

A Master Protocol for Randomized, Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis

Register Today!

Trial Information

Start DateMay 2023
End DateTBD
Trial DurationTBD
Number of VisitsTBD
Lead CRCJessica Richer
StatusIn Start-up

For additional information
on this trial contact: